About Us
About Guard Therapeutics
Vision, Business Model & Goal
The Board
Management
Research
Kidney disease
Science
Pipeline
RMC-035
GTX Peptides
Investor Relations
Financial calender
Financial reports
Share information
Corporate governance
General meetings
Rights Issue 2025
Newsroom
Press releases
Event calender
Analyses and presentations
Subscribe
Contact
Swe
Search
Analyses and presentations
Corporate Presentation
Corporate presentation
September 2025
Analyses
11 Sep 2025 / Redeye Initiation of Coverage September 11, 2025
https://guardtherapeutics.com/assets/uploads/Redeye-Initiation-of-Coverage-250911.pdf
25 Aug 2025 / Carnegie Access 22 August, 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250822.pdf
14 May 2025 / Carnegie Access 14 May, 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250514.pdf
08 Apr 2025 / Carnegie Access 8 April, 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250408.pdf
17 Mar 2025 / Carnegie Access news flash 14 March 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250314-news-flash.pdf
18 Feb 2025 / Carnegie Access 17 February 2025
https://guardtherapeutics.com/assets/uploads/Carnegie_250217.pdf
Presentations & interviews
16 Sep 2025 / CEO Tobias Agervald appears on BiotechTV
https://www.biotechtv.com/post/guard-therapeutics-september-16-2025
17 Oct 2024 / Guard presents at Redeye Theme "Cardiovascular & Metabolic Diseases Event 2024"
https://www.redeye.se/videoiframe/1044029
23 Sep 2024 / CEO Tobias Agervald appears on BiotechTV
https://www.biotechtv.com/post/guard-therapeutics-september-21-2024
19 Sep 2024 / Presentation at Pareto Securities' 15th Annual Healthcare Conference
https://guardtherapeutics.com/assets/uploads/Guard-Tx-Pareto-19Sept2024-final.pdf
30 Jan 2024 / Guard Therapeutics R&D update January 30, 2024
https://youtube.com/live/Enob5jUFw8I
23 Nov 2023 / Tobias Agervald presents at ABGSC Investor Days
https://www.youtube.com/watch?v=e2-bDLGMznk&list=PLgLifPc-PiGOhe-TjD_5jry8sc-EVJAoK&index=38